Chimerix Inc (NASDAQ: CMRX) kicked off on Monday, down -4.80% from the previous trading day, before settling in for the closing price of $0.96. Over the past 52 weeks, CMRX has traded in a range of $0.88-$1.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 292.67% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 8.76%. With a float of $79.36 million, this company’s outstanding shares have now reached $88.93 million.
In an organization with 72 employees, it is important to assess its efficiency.
Chimerix Inc (CMRX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Chimerix Inc is 11.04%, while institutional ownership is 46.03%. The most recent insider transaction that took place on Feb 14 ’24, was worth 2,777. In this transaction VP OF FINANCE AND ACCOUNTING of this company sold 2,660 shares at a rate of $1.04, taking the stock ownership to the 141,232 shares. Before that another transaction happened on Feb 14 ’24, when Company’s CHIEF FINANCIAL OFFICER sold 1,940 for $1.04, making the entire transaction worth $2,023. This insider now owns 110,999 shares in total.
Chimerix Inc (CMRX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 8.76% per share during the next fiscal year.
Chimerix Inc (NASDAQ: CMRX) Trading Performance Indicators
Take a look at Chimerix Inc’s (CMRX) current performance indicators. Last quarter, stock had a quick ratio of 10.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 254.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.96 in one year’s time.
Technical Analysis of Chimerix Inc (CMRX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.3 million. That was inferior than the volume of 0.4 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 16.73%. Additionally, its Average True Range was 0.06.
During the past 100 days, Chimerix Inc’s (CMRX) raw stochastic average was set at 7.58%, which indicates a significant increase from 7.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.97% in the past 14 days, which was lower than the 50.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0737, while its 200-day Moving Average is $1.0326. However, in the short run, Chimerix Inc’s stock first resistance to watch stands at $0.9559. Second resistance stands at $0.9973. The third major resistance level sits at $1.0246. If the price goes on to break the first support level at $0.8872, it is likely to go to the next support level at $0.8599. Assuming the price breaks the second support level, the third support level stands at $0.8185.
Chimerix Inc (NASDAQ: CMRX) Key Stats
The company with the Market Capitalisation of 81.59 million has total of 89,210K Shares Outstanding. Its annual sales at the moment are 320 K in contrast with the sum of -82,100 K annual income. Company’s last quarter sales were recorded 10 K and last quarter income was -23,990 K.
